SNYR Stock Analysis: Buy, Sell, or Hold?
SNYR - Synergy CHC Corp. Common Stock
$0.10
0.00 (3.57%)
β²
5d:
-32.54%
30d:
-38.71%
90d:
-59.02%
WAIT
LOW Confidence
Analysis Updated: Aug 24, 2026 12:00 AM ET
Earnings: Aug 27, 2026
2d
Get Alerted When SNYR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: SNYR is down 32.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: SNYR is down 32.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: SNYR is currently trading at $0.10, which is considered oversold relative to its 30-day fair value range of $0.13 to $0.19. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.7) compared to its historical average (3.1). Remarkably, the market is currently pricing in an annual earnings decline of 39.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNYR is in a downtrend. Immediate support is located at $0.09, while resistance sits at $0.18. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.75 (+3488.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNYR is in a downtrend. Immediate support is located at $0.09, while resistance sits at $0.18. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $3.75 (+3488.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.13 -
$0.19
Company Quality Score
52/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 3488.5% below Wall St target ($3.75)
- WARNING: Composite score 52/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.13 -
$0.19
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.09
Resistance Level
$0.18
Current Trend
Downtrend
Technical data as of
Aug 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.70
Wall Street Target
$3.75
(+3488.5%)
Revenue Growth (YoY)
-32.8%
Earnings Growth (YoY)
-90.6%
Profit Margin
-57.0%
Valuation Discount vs History
-39.0% cheaper
PE vs Historical
0.7 vs 3.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-39.0%
(market-implied from PE analysis)
1-Year Target
$0.09
(-10%)
2-Year Target
$0.08
(-19%)
3-Year Target
$0.08
(-27%)
3-Yr Target (if PE normalizes)
(PE: 1β3)
$0.34
(+224%)
π‘
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.7 to 3.1
Stabilization Target:
$0.46
(+345.0%)
PE Expansion Potential:
+345.0%
Share & Embed Analysis
Last updated: August 24, 2026 5:43 PM ET
Data refreshes hourly during market hours. Next update: 6:43 PM
Data refreshes hourly during market hours. Next update: 6:43 PM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNYR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$987 | 58 HOLD |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$369 | 54 HOLD |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$271 | 51 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$98 | 40 SELL |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |